No Data
No Data
Biofrontera Inc. Files to Sell 5.72M Shares of Common Stock for Holders
Express News | Biofrontera Shares Halted On Circuit Breaker To The Upside, Stock Now Up 17.1%
Biofrontera Shares Are Trading Higher After the Company Announced the Last Patient Completed the 1 Year Follow-up of Study ALA-BCC-CT013 in December 2024.
Biofrontera Announces Achievement Of Key Milestone In Phase 3 Study Of Ameluz-Photodynamic Therapy In The Treatment Of Superficial Basal Cell Carcinoma Was Met With The Last Patient Completing The 1 Year Follow-Up Visit In December Of 2024
Express News | Biofrontera Inc - Follow-up Data to Be Included in FDA Submission Expected Q3 2025
Express News | Biofrontera Inc. Announces Achievement of Key Milestone in Phase 3 Study of Ameluz®-Photodynamic Therapy (Pdt) in the Treatment of Superficial Basal Cell Carcinoma (Sbcc)
HailTheApocalypse : 1.19. not a good time to get in?
Jaguar8 OP HailTheApocalypse : Check indicators. It hasn’t reclaimed VWAP
HailTheApocalypse Jaguar8 OP : not sure what that is tbh but ok
Jaguar8 OP HailTheApocalypse : I already posted stock education you should use that
HailTheApocalypse Jaguar8 OP : will do! thank you